Olfr453 Inhibitors
Olfr453, a crucial member of the olfactory receptor gene family, plays a fundamental role in the intricate process of odorant signal transduction, leading to the perception of a diverse array of smells. As a G-protein-coupled receptor (GPCR) with a 7-transmembrane domain structure, Olfr453 is responsible for recognizing and mediating the G protein-mediated transduction of odorant signals within the nasal cavity. The unique singular coding-exon genes and independent nomenclature associated with Olfr453 contribute to the complexity of the olfactory system, emphasizing its distinctive role within the genome.
Inhibition of Olfr453 involves a sophisticated interplay of direct and indirect mechanisms, each intricately influencing the receptor's function. Direct inhibitors, such as Benzaldehyde and Cycloheximide, directly interfere with the binding of odorant molecules to Olfr453, disrupting G protein-mediated transduction and subsequently diminishing neuronal responses. On the other hand, indirect inhibitors like Forskolin and Wortmannin modulate specific cellular pathways associated with Olfr453 function. Forskolin, for instance, activates adenylate cyclase, leading to the modulation of cAMP levels and altering the responsiveness of Olfr453 to odorants. Similarly, Wortmannin targets the PI3K-Akt signaling pathway, indirectly influencing Olfr453 and contributing to altered olfactory signal transduction. This intricate interplay between direct and indirect inhibitors highlights the multifaceted nature of Olfr453's regulation and its indispensable role in shaping our perception of smells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thiourea | 62-56-6 | sc-213038 | 50 g | $38.00 | ||
Direct inhibitor competitively binding to Olfr453, impeding odorant interaction and disrupting normal signal transduction. This inhibits the receptor's role in initiating neuronal responses, affecting the overall perception of smells. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Indirect inhibitor influencing the folate metabolic pathway associated with Olfr453. This disruption indirectly modulates receptor function, altering the perception of specific odorants through cellular process changes. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
Direct inhibitor altering ion channels related to olfactory signal transduction, influencing Olfr453 responsiveness to odorants. This disruption decreases neuronal responses, impairing the overall perception of smells associated with Olfr453 activation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Indirect inhibitor affecting glucose metabolism pathways linked to Olfr453. Impaired energy supply hampers signal transduction, leading to altered functionality of the olfactory receptor, diminishing the perception of specific odorants. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Direct inhibitor inhibiting protein synthesis processes crucial for Olfr453 functionality. Reduced expression and activity of the receptor result in impaired odorant perception, impacting the overall smell perception associated with Olfr453 activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Indirect inhibitor targeting the PI3K-Akt signaling pathway linked to Olfr453. Modulation of this pathway indirectly influences olfactory signal transduction, leading to altered responsiveness of the olfactory receptor to odorants. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Direct inhibitor modulating the cAMP signaling pathway associated with Olfr453. Altered cAMP levels influence olfactory receptor function, leading to impaired perception of specific odorants recognized by Olfr453. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Indirect inhibitor affecting intracellular calcium levels linked to Olfr453 signal transduction. Disruption of calcium homeostasis indirectly influences receptor function, altering neuronal responses and diminishing the perception of smells associated with Olfr453 activation. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
Direct inhibitor binding to Olfr453 and inhibiting its activity. This interference disrupts the normal olfactory signal transduction, resulting in a diminished perception of specific odorants recognized by Olfr453. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Indirect inhibitor modulating the glucocorticoid receptor pathway associated with Olfr453. This modulation indirectly influences olfactory signal transduction, altering the sensitivity of the olfactory receptor protein to specific odorant molecules. | ||||||